HealthMap

Saccharomyces boulardii and Clostridium difficile

Overview of Saccharomyces boulardii

• It is a non-pathogenic probiotic yeast frequently utilized for gastrointestinal health.
• Unlike bacterial probiotics, it is unaffected by antibiotics, making it a common choice during antibiotic therapy.

Mechanisms Against C. diff

• Toxin Neutralization: Saccharomyces boulardii secretes a protease that degrades Clostridium difficile toxins A and B, and inhibits their binding to intestinal receptors.
• Microbiome Support: It helps maintain the integrity of the intestinal mucosa and supports a balanced microbial environment, reducing the opportunity for C. diff overgrowth.
• Immune Modulation: It stimulates the production of secretory IgA in the intestines, enhancing local immune defense.

Clinical Relevance

• Research and clinical observations indicate that co-administration of Saccharomyces boulardii with antibiotics significantly reduces the incidence of antibiotic-associated diarrhea (AAD) and recurrent Clostridium difficile infections.
• It is generally considered safe for the majority of individuals, though caution is advised in patients who are severely immunocompromised or critically ill.